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The biological behaviour of 23 Trypanosoma cruzi isolates in Swiss mice was compared. Nineteen isolates
were obtained from patients in the acute phase of Chagas disease (13), sylvatic reservoir hosts (Didelphis
marsupialis) (3), and triatomine bugs (Rhodnius robustus) (3) from four regions of the State of Amazonas
(AM). Four isolateswere obtained from chronic chagasic patients in the State of Paraná (PR): three autocht-
hones, and one allochthone from the State of Minas Gerais. Only one isolate was unable to infect the mice.
The AM and PR isolates showed the largest number of signiﬁcant differences from each other. The former
had lower mean values in the pre-patent (5.4 days) and patent (4.6 days) periods (PP), with the parasita-
emia (Pmax) reaching a peak of 9.9  104 blood trypomastigotes (BT)/mL of blood by the 7th day following
inoculation. The AM isolates also had higher positivity to fresh-blood examination (FBE) (84.1%) compared
to haemoculture (HC) (58.7%) and polymerase chain reaction (PCR) (33.3%), in addition to higher mortality
(2.9%). The PR isolates had higher values for PP (18.5 days) and Pmax (99.9  104 BT/mL) as well as higher
positivity to FBE (87.2%), HC (100%), and PCR (83.3%). The correlations between the biological behaviour of
the T. cruzi isolates and the clinical and epidemiological characteristics of Chagas disease are discussed.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction soma cruzi. Its geographic distribution and those of its vectorsChagas disease (ChD) is a parasitic condition affecting humans,
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sevier OA license.and reservoirs extend from the southern United States to Argentina
and Chile, affecting 21 countries. The number of T. cruzi-infected
individuals in the endemic areas of Latin America has gradually de-
creased from 16–18 million in the 1980s to 8 million in 2007
(WHO, 2007). However, the annual incidence currently ranges
from 100,000 to 200,000, and ChD is the third most common par-
asitic infection worldwide, behind only malaria and schistosomia-
sis, causing 12,500 deaths per year (Moncayo and Silveira, 2009).
Experimental studies have demonstrated that T. cruzi has great
biological and genetic variability (Andrade and Magalhães, 1997;
Brener, 1962; Miles et al., 2003; Toledo et al., 2002). Population
genetics studies show that although this species is diploid, it exhib-
its a predominantly long-term clonal evolution and structure with
rare events of gene exchange, which suggests a correlation between
its genetic divergence and its biological and clinical properties
(Tibayrenc and Ayala, 1988). Various terminologies have been ap-
plied to the several main subgroups, including biodemes (Andrade
and Magalhães, 1997), zymodemes (Miles et al., 2003), lineage
(Anonymous, 1999), andmore recently, discrete typing units (DTUs)
(Brisse et al., 2000). Themost recent consensus on T. cruzinomencla-
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(Zingales et al., 2009). Recognition of this genetic diversity is of fun-
damental importance in comparing the biological behaviour of T.
cruzi isolates from different geographic areas and hosts.
In the Amazon region, deforestation, substandard housing con-
ditions in rural areas, and harvesting of forest products have in-
creased contact between peri-domiciliary vectors, sylvatic
reservoirs, and humans, which also increases the number of cases
of ChD that apparently originate from sylvatic transmission in these
locales (Aguilar et al., 2007; Brum-Soares et al., 2010; Coura et al.,
2002; Miles et al., 1981; Valente et al., 2008). Recent clinical epide-
miological studies found that cases of ChD in the Amazon region
were the result of ingestion of food contaminated by faeces from
sylvatic animals and vectors, indicating an oral form of transmis-
sion (Pinto et al., 2008; Valente et al., 2008).The relative frequency
of clinical forms of ChD varies with geographic area, but in the Bra-
zilian Amazon, chronic cases were found only in latent and sporadic
cardiac forms (Brum-Soares et al., 2010). Cross-sectional studies
conducted in the Rio Negro micro-region demonstrated that the
mild severity proﬁle in the chronic phase of the disease is attribut-
able to the low levels of parasitaemia and low pathogenic potentialFig. 1. Map of Brazil indicating the states of Amazonas, Paraná, and Minas Gerais, as well
study.of sylvatic strains of T. cruzi circulating in the region (Coura et al.,
1999, 2002). In the Venezuela and Brazilian Amazon where T. cruzi
I (TcI) is predominant, both acute and chronic cardiac forms of Cha-
gas disease exist, but the digestive form has never been reported
(Añez et al., 2004; Miles et al., 1981, 2003).
New cases of ChD rarely occur in southern Brazil, although this
is an ancient endemic area, and the great majority of cases are in
the chronic phase. Similarly, in the domestic transmission cycles
of T. cruzi in the Southern Cone countries of South America, where
T. cruzi II (TcII) is predominant, including the State of Paraná (PR) in
Brazil (Zalloum et al., 2005), patients may show digestive mega-
syndromes or cardiac changes, or both (Bozelli et al., 2006).
The genetic diversity of the parasite can translate into distinct
biological, pathological, clinical, immunological, and biochemical
characteristics (Andrade and Magalhães, 1997; Brener, 1962; Miles
et al., 1981, 2003; Tibayrenc and Ayala, 1988; Toledo et al., 2002).
Study of the biological diversity of T. cruzi isolates circulating in the
Amazon region is important for the understanding of the emer-
gence and spread of ChD, and is essential for determining the asso-
ciation between parasitological parameters and the clinical-
epidemiological picture of chagasic infection in the region. Theas the municipalities and hosts where Trypanosoma cruzi isolates were obtained for
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isolates from human, triatomine, and sylvatic mammal hosts living
in the state of Amazonas (northern Brazil), and compared them to
isolates from the state of Paraná (southern Brazil).
2. Materials and methods
2.1. Ethical aspects
Acquisition of T. cruzi isolates from humans living in Amazonas
(AM) was approved by the Research Ethics Committee of the Ama-
zonas Tropical Medicine Foundation (protocol number 360/07).
The use of isolates from humans living in Paraná (PR) was ap-
proved by the Human Research Ethics Committee of the State Uni-
versity of Maringá (UEM) (protocol numbers 100/04 and 375/07).
The patients diagnosed with ChD provided informed consent for
the use of T. cruzi isolates, and were treated according to the guide-
lines of the Ministry of Health. The use of animals was authorised
and approved by the UEM Animal Research Ethics Committee (pro-
tocol number 113/09).
2.2. Study areas
The state of Amazonas is located in northern Brazil (2010S,
73480W), and covers an area of 1,570,946 km2, including 62
municipalities (Fig. 1). The population in 2010 was estimated at
3,480,937, with 79.2% living in urban and 20.8% in rural areas.
The original vegetation cover is primarily dense ombrophilous for-
est. The climate according to the Köppen classiﬁcation is Af (super-
humid equatorial), with rainfall above 2000 mm per year and an-
nual mean temperatures from 26 to 28 C. The economy is mainly
extractive.
The state of Paraná is located in southern Brazil (24000S,
51000W), and covers an area of 199,880 km2, including 399
municipalities (Fig. 1). The population is 10,439,601, with 85.3%
living in urban and 14.7% in rural areas. The original vegetation
is semi-deciduous seasonal forest, which now persists mainly
along watercourses in valleys. The climate according to the KöppenTable 1
Isolation source, geographic origin, isolation method, and inoculum of the Trypanosoma cr
Isolate Isolation source Mu
MHOM/BR/2007/AM04 Acute chagasic patient Co
MHOM/BR/2007/AM05 Acute chagasic patient Co
MHOM/BR/2007/AM08 Acute chagasic patient Co
MHOM/BR/2007/AM10 Acute chagasic patient Co
MHOM/BR/2007/AM13 Acute chagasic patient Co
MHOM/BR/2007/AM14 Acute chagasic patient Co
MHOM/BR/2007/AM15 Acute chagasic patient Co
MHOM/BR/2007/AM18 Acute chagasic patient Co
MDID/BR/2008/AM30 Didelphis marsupialis Ma
MDID/BR/2008/AM32 Didelphis marsupialis Ma
TROB/BR/2008/AM37 Rhodnius robustus Co
MDID/BR/2008/AM39 Didelphis marsupialis Ma
TROB/BR/2009/AM56 Rhodnius robustus Ap
TROB/BR/2009/AM57 Rhodnius robustus Ap
MHOM/BR/2009/AM62 Acute chagasic patient SIR
MHOM/BR/2009/AM64 Acute chagasic patient SIR
MHOM/BR/2009/AM67 Acute chagasic patient SIR
MHOM/BR/2009/AM68 Acute chagasic patient SIR
MHOM/BR/2009/AM69 Acute chagasic patient SIR
MHOM/BR/2008/PR1219 Chronic chagasic patient Ma
MHOM/BR/2010/PR1226 Chronic chagasic patient Ma
MHOM/BR/2006/BS48 Chronic chagasic patient Co
MHOM/BR/2004/PR2259 Chronic chagasic patient Vir
a Abbreviations of Brazilian states: AM, Amazonas; MG, Minas Gerais; PR, Paraná.
b Number of blood trypomastigotes/animal.
c Number of metacyclic trypomastigotes in LIT/ animal.
d SIRN = Santa Isabel do Rio Negro.classiﬁcation is Cfa (humid temperate), with mean temperatures
from 20 to 22 C, and mild winters with dry periods between July
and September. The mean annual rainfall is 1600 mm.2.3. T. cruzi isolates from Amazonas
Nineteen AM isolates were obtained for study, 13 of them from
acute chagasic patients living in two different municipalities. The
other six isolates were obtained from triatomines (3) and sylvatic
reservoirs (3) (Fig. 1 and Table 1), all obtained at the Amazonas
Tropical Medicine Foundation (FMTAM), between April 2006 and
January 2010.
The 13 samples of T. cruzi isolated from chagasic patients were
cultured from 0.5 mL of blood inoculated into tubes containing
NNN medium and a layer of LIT (liver-infusion tryptose), plus
10% foetal bovine serum and 140 mg/mL gentamicin sulphate.
The cultures were incubated at 28 C, and the ﬂagellates’ growth
was monitored weekly.
Possums Didelphis marsupialis, from which three isolates of T.
cruzi were obtained, were captured by Tomahawk traps baited
with fruit. Capture and blood collection from these mammals were
authorised by the Brazilian Environment Institute (IBAMA), permit
number 1830651/2007. T. cruzi was isolated by haemoculture and
xenodiagnosis. The latter required fasted nymphs of Triatoma infe-
stans or Dipetalogaster maximus, which were obtained from the
FMTAM Entomology Unit. Readings were taken 30, 45, and 60 days
after the blood meal by compressing the insect’s abdomen for
observation of its faeces and urine under optical microscopy. If po-
sitive for ﬂagellates, the material was then inoculated in mice, and
haemoculture (Filardi and Brener, 1987) was performed after
30 days in order to recover T. cruzi samples.
Three T. cruzi isolates were obtained from Rhodnius robustus by
using Noireau traps installed in palm trees in sylvatic and perido-
mestic environments. The insects were morphologically identiﬁed
and dissected, and their intestinal contents were examined with
the use of a microscope. Positive samples for trypanosomes were
inoculated in mice, and the parasites were isolated through hae-
moculture (Filardi and Brener, 1987).uzi isolates studied.
nicipality/Statea Isolation method Inoculumb
ari/AM Haemoculture 1.4  103
ari/AM Haemoculture 1.0  104
ari/AM Haemoculture 2.8  103
ari/AM Haemoculture 2.1  103
ari/AM Haemoculture 2.8  103
ari/AM Haemoculture 1.5  104
ari/AM Haemoculture 1.2  104
ari/AM Haemoculture 1.0  104
naus/AM Xenodiagnosis 1.8  104
naus/AM Haemoculture 2.8  103
ari/AM Xenoculture 2.0  106c
naus/AM Haemoculture 2.8  103
uí/AM Inoculation in mice 2.0  106c
uí/AM Inoculation in mice 1.0  104
Nd/AM Haemoculture 1.0  104
N/AM Haemoculture 4.4  103
N/AM Haemoculture 1.0  104
N/AM Haemoculture 1.0  104
N/AM Haemoculture 7.6  103
ringá/PR Haemoculture 1.0  104
ringá/PR Haemoculture 1.2  104
lorado/PR Haemoculture 1.0  104
gem da Lapa/MG Haemoculture 1.0  104
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Four T. cruzi isolates were obtained from chronic chagasic pa-
tients living in Paraná, through haemoculture, and were main-
tained in LIT medium. Three autochthonous isolates were
obtained between 2006 and 2010, and an allochthonous one, iso-
lated from a patient from the State of Minas Gerais, in 1994
(Fig. 1 and Table 1).
After isolation and culture, the 23 isolates from AM and PR were
immediately cryo-preserved in liquid nitrogen (193 C) and
stored in the T. cruzi strain bank at the UEM Chagas Disease
Laboratory.
2.5. Animal inoculation
For each T. cruzi isolate, a group of 10 male Swiss mice aged 21–
28 days and weighing between 18 and 20 g was used. All the ani-
mals were supplied by the UEM Central Bioterium and were kept
under suitable temperature, humidity, and availability of water
and food ad libitum. Inoculation was performed intraperitoneally
(IP); the inoculum was calculated according to Brener (1962),
and ranged from 1.4  103 to 1.8  104 blood trypomastigotes
(BT)/animal depending on the virulence of the isolate (Table 1).
For experiments with two isolates (AM37 and AM56) that showed
sub-patent parasitaemia in Swiss mice, an inoculum of metacyclic
trypomastigotes (MT) (Araújo et al., 1999) was employed. The
number of parasites was calculated by using a Neubauer chamber,
with the subsequent calculation of the percentage of trypomastig-
otes in random counts of 500 forms on a Giemsa-stained slide. For
these experiments, the content of the inoculum was higher
(2.0  106 MT/animal) because the culture MT forms are less infec-
tive than the blood forms (Table 1).
2.6. Parasitological parameters
The parasitaemia curve was based on examination of trypom-
astigotes in the bloodstream. A fresh blood examination (FBE) was
carried out daily from the 3rd day after inoculation (d.a.i.) until a
negative result was obtained for at least three consecutive days in
the case of patent parasitaemia, or for a 30-day period in the case
of sub-patent parasitaemia. The parasites were counted in 5 lL of
blood collected from the animal’s tail, as described by Brener
(1962). In addition to the percentage of animals that showed a po-
sitive FBE (%+FBE), the mean pre-patent period (PPP), mean patent
period (PP),maximumpeak of parasitaemia (Pmax) and day ofmax-
imumpeak of parasitaemia (DPmax) were obtained for each isolate.
2.7. Haemoculture
On day 55 after inoculation (d.a.i.), 0.5 mL of blood was asepti-
cally collected from the retro-orbital plexus and placed in two
tubes, each containing 3 mL of LIT medium, according to Filardi
and Brener (1987). The cultures were maintained at 28 C and
monitored with the aid of microscopy for parasite growth at 30,
45, and 60 days after seeding. By this technique, the percentage
of mice showing positive haemoculture (%+HC) was obtained for
each isolate.
2.8. Polymerase chain reaction (PCR)
In order to conﬁrm the infectivity of T. cruzi isolates, PCR was
performed on the blood samples of mice that showed negative
FBE and HC. For determination of the percentage of mice with po-
sitive PCR (%+PCR), samples of all animals inoculated with four iso-
lates (AM30, AM57, AM67, and PR1226) were used, according to
Miyamoto et al. (2006).On day 55 after inoculation, 200 lL of blood was collected from
the retro-orbital plexus of each animal, in parallel with HC. DNA
was extracted according to Wincker et al. (1994), as modiﬁed by
Gomes et al. (1998). Primers 121 (50-AAATAATGTACGGG(T/
G)GAGATGCA TGA-30) and 122 (50-GGTTCGATTGGGGTTGGTGTAA-
TATA-30) were used for ampliﬁcation of a fragment of 330 base
pairs (bp) speciﬁc for the DNA minicircle of the kinetoplast (k-
DNA) of T. cruzi. The reaction mixture was submitted to 35 cycles
of ampliﬁcation with a thermocycler (Techne TC-512, UK). Reac-
tion conditions, electrophoresis, and revelation were described by
Gomes et al. (1998) and Miyamoto et al. (2006). Samples that
showed a 330-bp band in the gel were considered as a positive PCR.
2.9. Infectivity and mortality
The infectivity rate (%INF) was calculated as the percentage of
animals that showed a positive FBE within the ﬁrst two months
following inoculation, and/or a positive HC and/or PCR on the
55th day. Cumulative mortality (%MOR) was recorded each day
during the course of infection, and was calculated as the percent-
age of deaths observed in the entire period.
2.10. Statistical analysis
The results of experiments with 11 (AM05, AM15, AM18, AM57,
AM62, AM67, AM68, PR1219, BS48, PR1226, and PR2259) of the 23
isolates were submitted to statistical analysis in which inocula
ranging from 10,000 to 12,000 BT/animal were used. Statistical
comparisons of parasitological parameters were conducted be-
tween: (i) AM and PR isolates, (ii) isolates from different geo-
graphic areas of the Amazon (Coari  Santa Isabel), and (iii)
isolates from different sources (humans  triatomines).
Student’s parametric t-test and the non-parametric Mann–
Whitney test were employed to compare the parameters PPP, PP,
Pmax, and DPmax. The positivity of FBE, HC, PCR, INF, and MOR
was compared by the chi-square and Fisher’s exact tests. All results
were analysed with the Statistica software version 8.0 (StatSoft
Inc., USA) at a signiﬁcance level of 5%.3. Results
3.1. Parasitaemia curves
Fig. 2 shows the differences between the curve proﬁles for mean
parasitaemia in mice inoculated with T. cruzi isolates obtained
from different geographic regions and hosts: AM  PR (Fig. 2a),
Coari  Santa Isabel (Fig. 2b), and humans  triatomines (Fig. 2c).
Based on these parasitaemia data, PPP, PP, Pmax, and DPmax were
calculated for the isolates infecting the mice.
Table 2 lists the PPP values for the T. cruzi isolates, which ranged
from 2.9 days for one isolate (AM69) from Santa Isabel (AM), ob-
tained from an acute chagasic patient, to 12.8 days for two isolates
(AM37 and PR1219). Three isolates (AM30, AM39, and AM56)
showed sub-patent parasitaemia, and in those animals infected
with isolate PR2259 the PP was 25.9 days. Pmax reached
385.4  104 BT/1 mL of blood for one PR isolate (BS48). DPmax ran-
ged from day 4 for one isolate (AM13) from Coari (AM), obtained
from an acute-phase patient, to day 29 for one PR isolate (PR1219)
(Table 2).
3.2. Parasitological parameters
As shown in Table 3, the percentage of FBE positivity ranged
from zero for three isolates with sub-patent parasitaemia (AM30,
AM39, and AM56) to 100% for seven isolates (AM05, AM14,
Fig. 2. Mean parasitaemia curves in mice inoculated with 10,000–12,000 blood trypomastigotes of Trypanosoma cruzi isolates: (a) states of Amazonas and Paraná; (b)
municipalities of Coari and Santa Isabel do Rio Negro in Amazonas; (c) humans and triatomines from Amazonas.
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itivity ranged from 11.11% for one AM isolate (AM10) to 100% for
three PR isolates (BS48, PR12126, and PR2259). The percentage of
PCR positivity for the samples from all mice inoculated with four
isolates ranged from 28.6% for one AM isolate (AM67) to 83.3%
for one PR isolate (PR12126), and the intensity of the 330-bp band
in gel varied for some samples from the same T. cruzi isolate.
The infectivity rate was null for only one isolate obtained from
D. marsupialis (AM32); infectivity was high for the other 22 isolates
studied, of which nine had 100% infectivity (AM05, AM14, AM30,
AM57, AM64, AM67, AM69, PR1219 and BS48) (Table 3). The mor-tality rate was also null for 14 isolates, ranging from 10% to 30% for
eight AM isolates, and was 100% for one isolate (AM64).
3.3. Statistical comparisons
The AM and PR isolates of T. cruzi differed signiﬁcantly
(p < 0.001) in ﬁve of the nine parasitological parameters (Table
5): PPP, PP, Pmax, DPmax, and %HC+ (Table 4). T. cruzi isolates from
Coari and Santa Isabel differed signiﬁcantly in PPP (p < 0.05), PP
(p < 0.001), and Pmax (p < 0.001) (Tables 4 and 5). AM isolates of
T. cruzi from human and triatomines differed signiﬁcantly in three
Table 2
Means and standard deviations of four parasitological parameters derived from the parasitaemia curve in mice inoculated with Trypanosoma cruzi isolates obtained from the
states of Amazonas and Paraná.
Isolate Mean pre-patent
period (days)
Mean patent
period (days)
Maximum peak of
parasitaemia (104)a
Day of maximum peak
of parasitaemia
MHOM/BR/2007/AM04 5.8 ± 1.1 4.2 ± 1.5 4.8 ± 3.7 6.6 ± 1.5
MHOM/BR/2007/AM05 5.6 ± 1.6 4.0 ± 1.7 8.1 ± 5.6 7.3 ± 1.5
MHOM/BR/2007/AM08 9.5 ± 1.3 1.5 ± 1 1.9 ± 1.4 7.7 ± 3.9
MHOM/BR/2007/AM10 8.3 ± 2.4 2.9 ± 1.3 3.6 ± 2.3 9.7 ± 2.0
MHOM/BR/2007/AM13 5.3 ± 1.5 1.4 ± 1.7 1.7 ± 1.8 4 ± 3.8
MHOM/BR/2007/AM14 5.3 ± 2.6 6.6 ± 1.7 13.4 ± 7.3 7 ± 2.3
MHOM/BR/2007/AM15 9.2 ± 3.4 1.4 ± 1.1 1 ± 1.1 5.4 ± 5.9
MHOM/BR/2007/AM18 6.6 ± 2.1 1.8 ± 1.8 1.6 ± 1.2 6.3 ± 3.1
MDID/BR/2008/AM30 – 0 0 –
MDID/BR/2008/AM32 – 0 0 –
TROB/BR/2008/AM37 12.8 ± 0.7 1.8 ± 1.0 1.6 ± 0.9 12.6 ± 5.1
MDID/BR/2008/AM39 – 0 0 –
TROB/BR/2009/AM56 – 0 0 –
TROB/BR/2009/AM57 3.4 ± 1.5 6.9 ± 1.2 11.2 ± 3.2 7.7 ± 0.7
MHOM/BR/2009/AM62 6.9 ± 2.0 3.4 ± 1.1 6 ± 5.2 7.8 ± 1.8
MHOM/BR/2009/AM64 3.7 ± 0.5 7.6 ± 0.5 49.6 ± 33.5 7 ± 1.2
MHOM/BR/2009/AM67 4.6 ± 0.8 5.2 ± 1.7 27.7 ± 30.9 7.4 ± 0.5
MHOM/BR/2009/AM68 4.9 ± 2.3 6.3 ± 2.3 8.4 ± 3.8 8.3 ± 1.5
MHOM/BR/2009/AM69 2.9 ± 0.3 8.1 ± 3 46.9 ± 25.8 7.1 ± 2.6
MHOM/BR/2008/PR1219 12.8 ± 5.8 19.9 ± 5.1 9.9 ± 3.3 29.6 ± 12.4
MHOM/BR/2010/PR1226 4.2 ± 0.4 23.4 ± 4.2 385.4 ± 179.6 15.4 ± 4.0
MHOM/BR/2006/BS48 12.5 ± 2.3 4.7 ± 4.2 4.5 ± 3.7 12 ± 9.0
MHOM/BR/2004/PR2259 9.4 ± 4.6 25.9 ± 10 9.9 ± 4.6 19.2 ± 7.7
a Number of blood trypomastigotes/mL.
Table 3
Parasitological parameters in mice inoculated with Trypanosoma cruzi isolates
obtained from the states of Amazonas and Paraná.
Isolate %+FBEa %+HCb %+PCRc %INFd %MORe
MHOM/BR/2007/AM04 83.33 60.00 – 83.33 0.00
MHOM/BR/2007/AM05 100.00 71.43 – 100.00 10.00
MHOM/BR/2007/AM08 50.00 33.33 – 60.00 10.00
MHOM/BR/2007/AM10 77.77 11.11 – 77.77 0.00
MHOM/BR/2007/AM13 30.00 57.14 – 50.00 0.00
MHOM/BR/2007/AM14 100.00 28.57 – 100.00 25.00
MHOM/BR/2007/AM15 60.00 57.14 – 70.00 0.00
MHOM/BR/2007/AM18 70.00 20.00 – 80.00 10.00
MDID/BR/2008/AM30 0.00 90.00 80.00 100.00 20.00
MDID/BR/2008/AM32 0.00 0.00 – 0.00 0.00
TROB/BR/2008/AM37 63.63 45.45 – 72.72 0.00
MDID/BR/2008/AM39 0.00 85.71 – 60.00 20.00
TROB/BR/2009/AM56 0.00 87.50 – 87.50 12.50
TROB/BR/2009/AM57 100.00 16.66 40.00 100.00 0.00
MHOM/BR/2009/AM62 80.00 71.42 – 80.00 0.00
MHOM/BR/2009/AM64 100.00 – – 100.00 100.00
MHOM/BR/2009/AM67 100.00 85.71 28.57 100.00 0.00
MHOM/BR/2009/AM68 80.00 71.42 – 80.00 0.00
MHOM/BR/2009/AM69 90.00 14.28 – 100.00 30.00
MHOM/BR/2008/PR1219 100.00 – – 100.00 0.00
MHOM/BR/2010/PR1226 100.00 100.00 – 100.00 0.00
MHOM/BR/2006/BS48 60.00 100.00 83.30 90.00 0.00
MHOM/BR/2004/PR2259 90.00 100.00 – 90.00 0.00
a Percentage of mice with positive fresh blood examination.
b Percentage of mice with positive haemoculture.
c Percentage of mice with positive polymerase chain reaction.
d Infectivity rate.
e Mortality rate.
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5).
4. Discussion
The low parasitaemia observed for AM isolates of T. cruzi con-
cords with previous report (Junqueira et al., 2005), even though
this made it difﬁcult to use a standard inoculum of 1.0  104 BT/animal in all assays. Consequently, different inocula of blood try-
pomastigotes were used. In addition, inocula of cultured metacy-
clic trypomastigotes were required for two AM isolates, because
of difﬁculties in obtaining the blood forms in mice.
The T. cruzi isolates showed variation in the nine parasitological
parameters studied. Of the 23 isolates, only one was considered
non-infective for Swiss mice according to the results of FBE, HC,
and PCR; whereas the others were highly infective, with nine iso-
lates exhibiting 100% infectivity. The infectivity of different T. cruzi
strains can vary depending on their genotype, geographic origin,
and techniques for the detection of infection. Toledo et al. (2002)
reported signiﬁcant differences in infectivity in BALB/c mice
among TcI (formerly genotypes 19 and 20; Tibayrenc and Ayala,
1988), Tcll (formerly genotype 32; Tibayrenc and Ayala, 1988),
and TcV (formerly genotype 39; Tibayrenc and Ayala, 1988). The
percentage of infectivity (%INF) ranged from 22.2% to 100%
amongst the 20 clones studied, and the Tcl clones were more infec-
tive than the Tcll and TcV clones (Toledo, 2001). However, other
studies on T. cruzi isolates from the states of Amazonas, Rio de Ja-
neiro, and Piauí reported 100% infectivity for Swiss mice (Lisboa
et al., 2007).
In this study, three isolates obtained from D. marsupialis in
Amazonas were genetically characterised and classiﬁed as Tcl
(unpublished observations). These data are in agreement with pre-
vious reports that Didelphis shows a strong association with Tcl
(Steindel et al., 1995; Yeo et al., 2005). Of the three isolates, one
was unable to infect Swiss mice, and the other two had sub-patent
parasitaemia. Lisboa et al. (2007) found that Tcl isolates from dif-
ferent hosts showed low levels of parasitaemia, infectivity, and vir-
ulence in Swiss mice compared to TcII strains.
There are profound divergences in the biological behaviour of T.
cruzi strains obtained from D. marsupialis, mainly regarding the
parasitaemia in experimentally infected mice. According to the lit-
erature, mice inoculated with these strains can show long patent
periods and high levels of parasitaemia on the one hand (Lisboa
et al., 2007; Steindel et al., 1995; Toledo, 2001), or sub-patent par-
asitaemia on the other hand (Carneiro et al., 1991; Deane et al.,
1963; Steindel et al., 1995). Our ﬁndings accord with the latter
Table 4
Mean values of the nine parasitological parameters in mice inoculated with 10,000–12,000 blood trypomastigotes of Trypanosoma cruzi isolates grouped according to their
geographic origin and host.
Groups of T. cruzi isolates PPPa (days) PPb (days) Pmaxc (104) d DPmaxe %+FBEf %+HCg %+PCRh %INFi %MORj
Amazonas (AM) 5.44 4.25 9.89 7.71 84.06 58.70 33.33 86.96 2.90
Paraná (PR) 9.59 18.51 99.93 21.06 87.18 100.00 83.33 94.87 0.00
Coari (AM) 6.47 2.56 4.03 7.67 76.67 52.63 – 83.33 6.67
SIRN (AM) 5.38 4.96 15.08 7.77 86.67 76.20 – 86.67 0.00
Humans (AM) 5.84 3.78 9.66 7.72 81.67 65.00 28.57 85.00 3.33
Triatomines (AM) 3.44 6.89 11.20 7.67 100.00 16.67 40.00 100.00 0.00
a Mean pre-patent period.
b Mean patent period.
c Maximum peak of parasitaemia.
d Number of blood trypomastigotes/mL.
e Day of maximum peak of parasitaemia.
f Percentage of mice with positive fresh blood examination.
g Percentage of mice with positive haemoculture.
h Percentage of mice with positive polymerase chain reaction.
i Infectivity rate.
j Mortality rate.
Table 5
Statistical comparisons (p values) of the nine parasitological parameters in mice inoculated with 10,000–12,000 blood trypomastigotes of Trypanosoma cruzi isolates grouped
according to their geographic origin and host.
Parameters/comparisonsa Amazonas  Paraná Coari  SIRN Humans  Triatomines
Mean pre-patent period <0.001 <0.05 <0.005
Mean patent period <0.001 <0.001 <0.001
Maximum peak of parasitaemia <0.001 <0.001 <0.05
Day of maximum peak of parasitaemia <0.001 NS NS
Fresh blood examination NS NS NS
Haemoculture <0.001 NS NS
PCR NS – NS
Infectivity NS NS NS
Mortality NS NS NS
Number of signiﬁcant differences 5 3 3
a Mann–Whitney test, Student’s t-test, Fisher’s exact chi-square test; NS: non-signiﬁcant.
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mice. These differences in the biological behaviour of T. cruzi iso-
lates obtained from D. marsupialis may be related to the genetic
subdivisions within Tcl, which can contain at least three different
genotypes associated with different T. cruzi transmission cycles
(domestic, peri-domestic, and sylvatic) (Cura et al., 2010; Falla
et al., 2009).
The mortality rate from T. cruzi isolates ranged from nil, as 14
isolates caused no deaths in Swiss mice, indicating low virulence;
to intermediate virulence, with eight isolates causing 10–30% mor-
tality; to highly virulent, for one isolate (AM64) that killed all inoc-
ulated mice (100% mortality). Our data concord with the majority
of studies, which have reported that more than 80% of T. cruzi
strains isolated from humans, triatomines, and Latin American ani-
mals have low to intermediate virulence for mice (Araújo et al.,
1999; Carneiro et al., 1991; Fernandes et al., 1997; Gonzalez
et al., 1995; Steindel et al., 1995; Toledo, 2001; Toledo et al., 2002).
This study on the biological behaviour of T. cruzi isolates from
two different geographic areas, namely Amazonas and Paraná,
where Chagas disease shows very different epidemiological and
clinical characteristics, revealed several signiﬁcant differences. In
addition, isolates from the same region were more similar amongst
themselves than to those from the other region. For instance, AM
isolates (n = 7) had shorter PPP, earlier DPmax (around day 7 after
inoculation), and higher mortality, suggesting greater virulence;
whereas PR isolates (n = 4) had longer PP and delayed Pmax. How-
ever, infectivity was high for T. cruzi isolates from both regions
(87.0% for AM and 94.9% for PR), with no signiﬁcant difference.
In a recent study, mice inoculated with sylvatic T. cruzi from
North America belonging to the DTUs Tcl and TcIV (correspondingto Tclla of Brisse et al., 2000) exhibited high susceptibility to infec-
tion but no mortality or morbidity, indicating that these isolates
had low virulence for mice (Roellig and Yabsley, 2010). These data
differ in part from the present ﬁndings, as a variation in the mor-
tality rate was observed amongst mice infected with AM isolates,
despite the presence in the Amazon region of both DTUs (Tcl and
TcIV) in sylvatic primates, Rhodnius spp., and humans with acute
ChD associated with oral transmission (Aguilar et al., 2007; Coura
et al., 1999; Marcili et al., 2009). However, the methodological dif-
ferences between the two studies with respect to lineage and age
of the mice and the inoculum used may have affected the param-
eters analysed.
With regard to the other parameters, the PR isolates had higher
values for %+FBE, %+HC, and %+PCR compared to those of the AM
isolates, although %+PCR was determined for only one PR isolate
(PR1226). This may be due to the signiﬁcantly longer periods of
patent parasitaemia and higher levels of parasitaemia for the PR
isolates. Junqueira et al. (2005) also found low parasitaemia in
mice infected with T. cruzi obtained from different hosts in the re-
gion of Barcelos (AM).
Interestingly, only those mice infected with AM isolates showed
higher values for %+FBE compared to %+HC and %+PCR, although
PCR is considered a more sensitive technique (Gomes et al.,
1998; Miyamoto et al., 2006; Wincker et al., 1997). The perfor-
mance of the different diagnostic techniques is a controversial
matter in the Amazon region. In the state of Pará and in Venezuela,
tests to diagnose acute ChD have demonstrated lower sensitivity
(Parada et al., 1997; Pinto et al., 2008). A considerable proportion
of individuals have peripheral blood parasitaemia in the Brazilian
Amazon, despite the negative results of xenodiagnosis and haemo-
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haemoculture, xenodiagnosis, and PCR had a low performance in
chronic chagasic patients from the Amazon region, compared to
the values reported by other studies in endemic areas in southern
and south-eastern Brazil.
Another important practical aspect is related to the differences
observed in the sensitivity of diagnostic methods for ChD used in
different geographic areas, where different T. cruzi DTUs are in cir-
culation. For example, Bolivia and most of Brazil including Paraná
are regions where the circulating stocks of Tcll cause high levels
of parasitaemia and PCR shows higher sensitivity. This is in con-
trast to the scenario in Central America, Mexico, and areas of the
Brazilian Amazon, where Tcl shows low parasitaemias (Aguilar
et al., 2007; Lisboa et al., 2007; Wincker et al., 1994; Zalloum
et al., 2005).
The biological behaviour of the PR isolates, all obtained from
chronic chagasic patients, was similar amongst themselves as well
as to the behaviour of most T. cruzi strains studied previously by
Araújo et al. (1999). These authors found that T. cruzi strains iso-
lated from chronic patients living in Paraná have low to intermedi-
ate virulence for mice, with 90% of the strains causing no mortality.
Based on three (PPP, PP, Pmax) of the nine parasitological
parameters studied, the T. cruzi isolates from Santa Isabel (n = 3)
were more virulent for mice than were those from Coari (n = 3).
Although these municipalities are in the same state (AM), Coari
is located south of Manaus, whereas Santa Isabel lies in the
northern part of the state. Molecular characterisation with mini-
exon genes and sequencing of the cytochrome oxidase gene by
Monteiro et al. (2010) showed that T. cruzi isolates from Coari be-
longed to the DTU TcIII/TcIV, formerly Z3 (Miles et al., 1981). In the
Upper Rio Negro region, where the municipality of Santa Isabel is
located, TcI and TcIV are found predominantly amongst piaçava
palm collectors (Marcili et al., 2009). Therefore, it is probable that
these Coari and Santa Isabel isolates are indeed closely related
genetically.
What factors might explain the observed differences in biolog-
ical behaviour? An explanation may lie in the presence of two geo-
graphic barriers separating these regions: the Negro and Solimões
rivers. These river barriers may isolate populations of a parasite,
which show clonal patterns of evolution and reproduction (Tibay-
renc and Ayala, 1988), thus indicating different features that can be
detected by genetic and molecular analyses.
The comparison between the AM isolates from humans and
from R. robustus indicated three signiﬁcant differences in the
parameters PPP, PP, and Pmax. These variations may be due to dif-
ferences in the host as well as in the region of origin: the isolates
obtained from humans were circulating in the central (Coari) and
northern (Santa Isabel) regions of the state, whereas the isolates
from triatomines came from the south (Apuí). In addition, six T.
cruzi isolates from humans were compared, to only one from a tri-
atomine. Therefore, a larger sample size may be necessary to ade-
quately reﬂect the variations existing within these populations.5. Conclusions
The T. cruzi isolates from Amazonas, where TcI and TcIV are pre-
dominant, showed a shorter PPP and earlier DPmax compared to
the isolates from Paraná, indicating that they were more virulent,
and in fact caused up to 100% mortality in these animals. In con-
trast, the isolates from Paraná, where TcII predominates in the
domestic transmission cycle, showed a longer PP and 10-fold high-
er levels of parasitaemia, which resulted in high positivity in terms
of diagnosis. However, the isolates from Amazonas and Paraná
showed no signiﬁcant difference in terms of infectivity and mortal-
ity in Swiss mice.Role of the funding source
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